About Respira Therapeutics
Respira Therapeutics is a company based in Albuquerque (United States) founded in 2010 was acquired by Gossamer Bio in September 2025.. Respira Therapeutics has raised $9.11 million across 3 funding rounds from investors including Gossamer Bio, HHS and Sun Mountain Capital. The company has 6 employees as of December 31, 2021. Respira Therapeutics offers products and services including RT234-PAH. Respira Therapeutics operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Albuquerque, United States
- Employees 6 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Respira Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.11 M (USD)
in 3 rounds
-
Latest Funding Round
$224.94 K (USD), Grant
Aug 01, 2019
-
Investors
Gossamer Bio
& 3 more
-
Employee Count
6
as on Dec 31, 2021
-
Acquired by
Gossamer Bio
(Sep 25, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Respira Therapeutics
Respira Therapeutics offers a comprehensive portfolio of products and services, including RT234-PAH. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Inhaled treatment for pulmonary arterial hypertension to relieve breathlessness.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Respira Therapeutics
Respira Therapeutics has successfully raised a total of $9.11M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $224.94 thousand completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $224,939
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2019 | Amount | Grant - Respira Therapeutics | Valuation |
investors |
|
| Apr, 2017 | Amount | Series A - Respira Therapeutics | Valuation |
investors |
|
| Dec, 2013 | Amount | Series A - Respira Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Respira Therapeutics
Respira Therapeutics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Gossamer Bio, HHS and Sun Mountain Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on multiple sectors
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Respira Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Respira Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Respira Therapeutics Comparisons
Competitors of Respira Therapeutics
Respira Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Respira Therapeutics
Frequently Asked Questions about Respira Therapeutics
When was Respira Therapeutics founded?
Respira Therapeutics was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Where is Respira Therapeutics located?
Respira Therapeutics is headquartered in Albuquerque, United States. It is registered at Albuquerque, New Mexico, United States.
Is Respira Therapeutics a funded company?
Respira Therapeutics is a funded company, having raised a total of $9.11M across 3 funding rounds to date.
How many employees does Respira Therapeutics have?
As of Dec 31, 2021, the latest employee count at Respira Therapeutics is 6.
What does Respira Therapeutics do?
Respira is a product development-stage company focused on pulmonary delivery of therapeutics for respiratory diseases. It is applying its patented, high-efficiency AOS Dry Powder Inhaler (DPI) technologies to uniquely enable the highly targeted lung delivery of drugs to treat pulmonary diseases. building an internal pipeline and also seeking partnerships for the use of our DPI products with proprietary drugs. Its lead product is RT234AOS-DPI, a combination of RT234 (a proprietary inhaled formulation of an off-patent drug) and its patented AOS-DPI to treat Pulmonary Arterial Hypertension.
Who are the top competitors of Respira Therapeutics?
Respira Therapeutics's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Respira Therapeutics offer?
Respira Therapeutics offers RT234-PAH.
Who are Respira Therapeutics's investors?
Respira Therapeutics has 4 investors. Key investors include Gossamer Bio, HHS, Sun Mountain Capital, and Cottonwood Technology Fund.